Cargando…
Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World
In Spain, 1.5 million essential < 60-year-old workers were vaccinated with a first AstraZeneca vaccine dose. After assessing the cases of thrombosis with thrombocytopenia associated to this vaccine, the European Medicines Agency (EMA) supported the administration of 2 doses of the AstraZeneca vac...
Autores principales: | Dal-Ré, Rafael, Farré, Magí, Lucena, M. Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816848/ https://www.ncbi.nlm.nih.gov/pubmed/35131144 http://dx.doi.org/10.1016/j.jval.2021.12.011 |
Ejemplares similares
-
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
por: Towse, Adrian, et al.
Publicado: (2021) -
Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic
por: Murteira, Rodrigo, et al.
Publicado: (2022) -
Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios
por: Vásquez, William F., et al.
Publicado: (2021) -
Cost Utility of Vaccination Against COVID-19 in Brazil
por: Fernandes, Ricardo Ribeiro Alves, et al.
Publicado: (2022) -
Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan
por: Morales-Zamora, Gilberto, et al.
Publicado: (2022)